FMP
Evaxion Biotech A/S
EVAX
NASDAQ
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.
4.13 USD
-0.01 (-0.242%)
About
ceo
Mr. Christian Kanstrup M.Sc.
sector
Healthcare
industry
Biotechnology
website
https://www.evaxion-biotech.com
exchange
NASDAQ
Description
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.
CIK
0001828253
ISIN
US29970R2040
CUSIP
29970R105
Address
Dr. Neergaards Vej
Phone
45 53 53 18 50
Country
DK
Employee
49
IPO Date
Feb 5, 2021
Summary
CIK
0001828253
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
29970R105
ISIN
US29970R2040
Country
DK
Price
4.13
Beta
-0.02
Volume Avg.
137.88k
Market Cap
21.54M
Shares
-
52-Week
2.824-18.5
DCF
-1.72
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.51
P/B
-
Website
https://www.evaxion-biotech.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest EVAX News
It looks like there's no news available.
